A citation-based method for searching scientific literature

Hyo-Jin Jeong, Robert J Vandenberg, Christopher W Vaughan. Br J Pharmacol 2010
Times Cited: 42







List of co-cited articles
981 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Identification of a new class of molecules, the arachidonyl amino acids, and characterization of one member that inhibits pain.
S M Huang, T Bisogno, T J Petros, S Y Chang, P A Zavitsanos, R E Zipkin, R Sivakumar, A Coop, D Y Maeda, L De Petrocellis,[...]. J Biol Chem 2001
228
47

Actions of N-arachidonyl-glycine in a rat neuropathic pain model.
Leeza A Q Vuong, Vanessa A Mitchell, Christopher W Vaughan. Neuropharmacology 2008
63
42

N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor.
Douglas McHugh, Sherry S J Hu, Neta Rimmerman, Ana Juknat, Zvi Vogel, J Michael Walker, Heather B Bradshaw. BMC Neurosci 2010
192
40

Identification of N-arachidonylglycine as the endogenous ligand for orphan G-protein-coupled receptor GPR18.
Masashi Kohno, Hitoshi Hasegawa, Atsushi Inoue, Masatake Muraoka, Tatsuhiko Miyazaki, Keizo Oka, Masaki Yasukawa. Biochem Biophys Res Commun 2006
166
35

N-Arachidonyl-glycine inhibits the glycine transporter, GLYT2a.
Amy L Wiles, Rhonda-Jo Pearlman, Mari Rosvall, Karin R Aubrey, Robert J Vandenberg. J Neurochem 2006
66
30

Resolution of inflammation by N-arachidonoylglycine.
Sumner H Burstein, Catherine A McQuain, Alonzo H Ross, Rebecca A Salmonsen, Robert E Zurier. J Cell Biochem 2011
42
30

Structural requirements for binding of anandamide-type compounds to the brain cannabinoid receptor.
T Sheskin, L Hanus, J Slager, Z Vogel, R Mechoulam. J Med Chem 1997
221
28

Actions of N-arachidonyl-glycine in a rat inflammatory pain model.
Rebecca Succar, Vanessa A Mitchell, Christopher W Vaughan. Mol Pain 2007
50
28

The endocannabinoid anandamide is a precursor for the signaling lipid N-arachidonoyl glycine by two distinct pathways.
Heather B Bradshaw, Neta Rimmerman, Sherry Shu-Jung Hu, Valery M Benton, Jordyn M Stuart, Kim Masuda, Benjamin F Cravatt, David K O'Dell, J Michael Walker. BMC Biochem 2009
79
28


Deletion of the mouse glycine transporter 2 results in a hyperekplexia phenotype and postnatal lethality.
Jesús Gomeza, Koji Ohno, Swen Hülsmann, Wencke Armsen, Volker Eulenburg, Diethelm W Richter, Bodo Laube, Heinrich Betz. Neuron 2003
230
26


Spinal antiallodynia action of glycine transporter inhibitors in neuropathic pain models in mice.
Katsuya Morita, Naoyo Motoyama, Tomoya Kitayama, Norimitsu Morioka, Koki Kifune, Toshihiro Dohi. J Pharmacol Exp Ther 2008
96
26

Glycine transport inhibitors for the treatment of pain.
Robert J Vandenberg, Renae M Ryan, Jane E Carland, Wendy L Imlach, Macdonald J Christie. Trends Pharmacol Sci 2014
49
26

Extracellular loops 2 and 4 of GLYT2 are required for N-arachidonylglycine inhibition of glycine transport.
Amelia R Edington, Audra A McKinzie, Aaron J Reynolds, Michael Kassiou, Renae M Ryan, Robert J Vandenberg. J Biol Chem 2009
25
40


N-arachidonoyl glycine induces macrophage apoptosis via GPR18.
Rina Takenouchi, Kazuhiko Inoue, Yuki Kambe, Atsuro Miyata. Biochem Biophys Res Commun 2012
40
25

Oleoyl-L-carnitine inhibits glycine transport by GlyT2.
J E Carland, R E Mansfield, R M Ryan, R J Vandenberg. Br J Pharmacol 2013
22
45

Reversible inhibition of the glycine transporter GlyT2 circumvents acute toxicity while preserving efficacy in the treatment of pain.
A Mingorance-Le Meur, P Ghisdal, B Mullier, P De Ron, P Downey, C Van Der Perren, V Declercq, S Cornelis, M Famelart, J Van Asperen,[...]. Br J Pharmacol 2013
36
27

Lipid G protein-coupled receptor ligand identification using beta-arrestin PathHunter assay.
Hong Yin, Alan Chu, Wei Li, Bin Wang, Fabiola Shelton, Francella Otero, Deborah G Nguyen, Jeremy S Caldwell, Yu Alice Chen. J Biol Chem 2009
226
21

Glycine transporter inhibitors as a novel drug discovery strategy for neuropathic pain.
Toshihiro Dohi, Katsuya Morita, Tomoya Kitayama, Naoyo Motoyama, Norimitsu Morioka. Pharmacol Ther 2009
77
21

T-type calcium channel inhibition underlies the analgesic effects of the endogenous lipoamino acids.
Guillaume Barbara, Abdelkrim Alloui, Joël Nargeot, Philippe Lory, Alain Eschalier, Emmanuel Bourinet, Jean Chemin. J Neurosci 2009
67
21

Activation of GPR18 by cannabinoid compounds: a tale of biased agonism.
Linda Console-Bram, Eugen Brailoiu, Gabriela Cristina Brailoiu, Haleli Sharir, Mary E Abood. Br J Pharmacol 2014
89
21

Inactivation of the glycine transporter 1 gene discloses vital role of glial glycine uptake in glycinergic inhibition.
Jesús Gomeza, Swen Hülsmann, Koji Ohno, Volker Eulenburg, Katalin Szöke, Diethelm Richter, Heinrich Betz. Neuron 2003
235
19

Regulation of anandamide tissue levels by N-arachidonylglycine.
Sumner H Burstein, Susan M Huang, Timothy J Petros, Ronald G Rossetti, J Michael Walker, Robert B Zurier. Biochem Pharmacol 2002
51
19

The endocannabinoid N-arachidonoyl glycine (NAGly) inhibits store-operated Ca2+ entry by preventing STIM1-Orai1 interaction.
Andras T Deak, Lukas N Groschner, Muhammad Rizwan Alam, Elisabeth Seles, Alexander I Bondarenko, Wolfgang F Graier, Roland Malli. J Cell Sci 2013
20
40


Glycine transporters are differentially expressed among CNS cells.
F Zafra, C Aragón, L Olivares, N C Danbolt, C Giménez, J Storm-Mathisen. J Neurosci 1995
420
19

A GPR18-based signalling system regulates IOP in murine eye.
Meggie D Caldwell, Sherry Shu-Jung Hu, Suresh Viswanathan, Heather Bradshaw, Melanie E M Kelly, Alex Straiker. Br J Pharmacol 2013
45
19


Molecular basis for substrate discrimination by glycine transporters.
Robert J Vandenberg, Kim Shaddick, Pengchu Ju. J Biol Chem 2007
49
16


Glycine transporters: essential regulators of neurotransmission.
Volker Eulenburg, Wencke Armsen, Heinrich Betz, Jesús Gomeza. Trends Biochem Sci 2005
242
16

The orphan receptor GPR55 is a novel cannabinoid receptor.
E Ryberg, N Larsson, S Sjögren, S Hjorth, N-O Hermansson, J Leonova, T Elebring, K Nilsson, T Drmota, P J Greasley. Br J Pharmacol 2007
980
16

Potential anti-inflammatory actions of the elmiric (lipoamino) acids.
Sumner H Burstein, Jeffrey K Adams, Heather B Bradshaw, Cristian Fraioli, Ronald G Rossetti, Rebecca A Salmonsen, John W Shaw, J Michael Walker, Robert E Zipkin, Robert B Zurier. Bioorg Med Chem 2007
38
18


A structure-activity relationship study on N-arachidonoyl-amino acids as possible endogenous inhibitors of fatty acid amide hydrolase.
Maria Grazia Cascio, Alberto Minassi, Alessia Ligresti, Giovanni Appendino, Sumner Burstein, Vincenzo Di Marzo. Biochem Biophys Res Commun 2004
51
16

Selective oxygenation of N-arachidonylglycine by cyclooxygenase-2.
Jeffery J Prusakiewicz, Philip J Kingsley, Kevin R Kozak, Lawrence J Marnett. Biochem Biophys Res Commun 2002
56
16

Isolation and structure of a brain constituent that binds to the cannabinoid receptor.
W A Devane, L Hanus, A Breuer, R G Pertwee, L A Stevenson, G Griffin, D Gibson, A Mandelbaum, A Etinger, R Mechoulam. Science 1992
16

N-arachidonoyl L-serine, an endocannabinoid-like brain constituent with vasodilatory properties.
Garry Milman, Yehoshua Maor, Saleh Abu-Lafi, Michal Horowitz, Ruth Gallily, Sandor Batkai, Fong-Ming Mo, Laszlo Offertaler, Pal Pacher, George Kunos,[...]. Proc Natl Acad Sci U S A 2006
122
16

Identification of farnesyl pyrophosphate and N-arachidonylglycine as endogenous ligands for GPR92.
Da Young Oh, Jung Min Yoon, Mi Jin Moon, Jong-Ik Hwang, Han Choe, Ju Yeon Lee, Jae Il Kim, Sunoh Kim, Hyewhon Rhim, David K O'Dell,[...]. J Biol Chem 2008
98
16


N-Arachidonoyl glycine suppresses Na⁺/Ca²⁺ exchanger-mediated Ca²⁺ entry into endothelial cells and activates BK(Ca) channels independently of GPCRs.
Alexander I Bondarenko, Konstantin Drachuk, Olga Panasiuk, Vadim Sagach, Andras T Deak, Roland Malli, Wolfgang F Graier. Br J Pharmacol 2013
19
36

Glycinergic dysfunction in a subpopulation of dorsal horn interneurons in a rat model of neuropathic pain.
Wendy L Imlach, Rebecca F Bhola, Sarasa A Mohammadi, Macdonald J Christie. Sci Rep 2016
31
22

The first potent and selective inhibitors of the glycine transporter type 2.
W L Caulfield, I T Collie, R S Dickins, O Epemolu, R McGuire, D R Hill, G McVey, J R Morphy, Z Rankovic, H Sundaram. J Med Chem 2001
73
16

Synthesis and Characterization of Novel Acyl-Glycine Inhibitors of GlyT2.
Shannon N Mostyn, Jane E Carland, Susan Shimmon, Renae M Ryan, Tristan Rawling, Robert J Vandenberg. ACS Chem Neurosci 2017
18
38

Modulation of N-methyl-D-aspartate receptor function by glycine transport.
R Bergeron, T M Meyer, J T Coyle, R W Greene. Proc Natl Acad Sci U S A 1998
337
14

International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂.
R G Pertwee, A C Howlett, M E Abood, S P H Alexander, V Di Marzo, M R Elphick, P J Greasley, H S Hansen, G Kunos, K Mackie,[...]. Pharmacol Rev 2010
14

Crystal structure of a bacterial homologue of Na+/Cl--dependent neurotransmitter transporters.
Atsuko Yamashita, Satinder K Singh, Toshimitsu Kawate, Yan Jin, Eric Gouaux. Nature 2005
14

A shared vesicular carrier allows synaptic corelease of GABA and glycine.
Sonja M Wojcik, Shutaro Katsurabayashi, Isabelle Guillemin, Eckhard Friauf, Christian Rosenmund, Nils Brose, Jeong-Seop Rhee. Neuron 2006
253
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.